Cours Isodiol International Inc. Canadian Securities Exchange
Actions
ISOL
CA46500L2003
Produits pharmaceutiques
CA 2018 | 19,14 M 26,1 M 17,13 M | CA 2019 | 22,25 M 30,34 M 19,92 M | Capitalisation | 49,96 M 68,14 M 44,73 M |
---|---|---|---|---|---|
Résultat net 2018 | -36 M -49,1 M -32,23 M | Résultat net 2019 | -126 M -172 M -113 M | VE / CA 2018 | 12,6 x |
Trésorerie nette 2018 | 15,55 M 21,21 M 13,92 M | Dette nette 2019 | 5,22 M 7,12 M 4,68 M | VE / CA 2019 | 2,48 x |
PER 2018 |
-4,94
x | PER 2019 |
-0,37
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+27,19% | 5,56 Md | |
-33,59% | 3,52 Md | |
-2,97% | 3,01 Md | |
-24,21% | 2,65 Md | |
-10,11% | 2,3 Md | |
+43,66% | 1,91 Md | |
+46,15% | 1,5 Md | |
-13,92% | 1,41 Md | |
+41,90% | 1,37 Md |